The phone is warm in my hand. Not hot, just the low-grade fever of a device that never truly sleeps. My thumb hovers, a stupid little hawk, over a small green icon. The line for the coffee isn’t moving. The air smells like burnt beans and something vaguely like cinnamon. Someone’s phone is playing a tinny video of a laughing baby, a sound that cuts through the low murmur of the café. I could be doing anything else. I could be looking out the window. I could be thinking about the project I need to finish. Instead, I’m here, about to shrink my entire financial future into a pane of glass measuring six-point-something inches diagonally.
Tap. The app opens. It’s a cascade of red and green, a language I’ve taught myself to read not with my brain, but with my gut. Red is a lurch in the stomach. Green is a little flutter of release. There’s a biotech stock, one I’ve vaguely followed, that’s up 9%. Why? I don’t know. A headline flashes below it, something about ‘promising trial results.’ I haven’t read the paper. I don’t know the sample size. I don’t know the difference between Phase 1 and Phase 2 trials without looking it up. But the light is green and the number is climbing and the coffee line still hasn’t moved.
Biotech Stock Soars
Correction Issued
My thumb, acting of its own volition, taps again.